| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 5FJL6W0640 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | Macrophage colony stimulating factor receptor antagonist |
| Primary Target | |
|---|---|
| colony stimulating factor 1 receptor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Carcinoma, Hepatocellular | 2 | D006528 | ClinicalTrials |
| Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
| Lymphoma, T-Cell, Peripheral | 2 | D016411 | ClinicalTrials |
| Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
| Arthritis, Rheumatoid | 1 | D001172 | ClinicalTrials |
| Synovitis, Pigmented Villonodular | 1 | D013586 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1613144-80-1 |
| ChEMBL | CHEMBL4297713 |
| FDA SRS | 5FJL6W0640 |
| Guide to Pharmacology | 9107 |
CONTENTS